Zhao Songfeng, Cao Yangbin, Liu Hongyi, Liu Aihua
The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Nutr J. 2025 Jan 24;24(1):14. doi: 10.1186/s12937-024-01062-9.
The evidence regarding dietary antioxidant intake and all-cause and cardiovascular disease (CVD) mortality among patients with hypertension is scarce.
This study included 16,190 adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. Death outcomes were ascertained by linkage to National Death Index records through December 31, 2019. Overall dietary intake was estimated with composite dietary antioxidant index (CDAI). Cox proportional hazards models were used to estimate the risk for all-cause and CVD mortality. Kaplan-Meier curve was used to illustrate the survival probabilities among CDAI quartiles. Weighted quantile sum (WQS) regression was conducted to evaluate the joint and independent associations of antioxidants with all-cause and CVD mortality. The median (interquartile range) age of participants was 59.00 (47.00, 69.00) years. During a median of 94 months of follow-up, 3,858 deaths were documented. Compared to participants with the lowest quartile of CDAI, the multivariable adjusted HR and 95% CI for participants with the highest quartile was 0.76 (0.64, 0.91) for all-cause mortality. The highest quartile (Q4) of vitamin E (HR = 0.69; 95% CI, 0.59-0.80), selenium (HR = 0.84; 95% CI, 0.70-1.00) and total carotenoids (HR = 0.86; 95% CI, 0.75-0.98) intakes were negatively associated with all-cause mortality. Vitamin E and selenium intakes might be the major contributors to this negative relationship. The highest quartile (Q4) of vitamin E (HR = 0.72; 95% CI, 0.56-0.93) intake was negatively associated with CVD mortality.
Higher overall dietary antioxidant intake was significantly associated with decreased all-cause and CVD mortality among patients with hypertension. Further randomized controlled trials are required to confirm our findings.
关于高血压患者膳食抗氧化剂摄入量与全因死亡率和心血管疾病(CVD)死亡率的证据很少。
本研究纳入了1999 - 2018年美国国家健康与营养检查调查(NHANES)中的16190名成年高血压患者。通过与截至2019年12月31日的国家死亡指数记录进行关联来确定死亡结局。总体膳食摄入量用综合膳食抗氧化剂指数(CDAI)进行估计。采用Cox比例风险模型来估计全因死亡率和CVD死亡率的风险。使用Kaplan - Meier曲线来说明CDAI四分位数之间的生存概率。进行加权分位数和(WQS)回归以评估抗氧化剂与全因死亡率和CVD死亡率的联合及独立关联。参与者的年龄中位数(四分位间距)为59.00(47.00,69.00)岁。在中位随访94个月期间,记录了3858例死亡。与CDAI最低四分位数的参与者相比,最高四分位数参与者的全因死亡率多变量调整后的HR及95%CI为0.76(0.64,0.91)。维生素E(HR = 0.69;95%CI,0.59 - 0.80)、硒(HR = 0.84;95%CI,0.70 - 1.00)和总类胡萝卜素(HR = 0.86;95%CI,0.75 - 0.98)摄入量的最高四分位数(Q4)与全因死亡率呈负相关。维生素E和硒的摄入量可能是这种负相关关系的主要贡献因素。维生素E摄入量的最高四分位数(Q4)(HR = 0.72;95%CI,0.56 - 0.93)与CVD死亡率呈负相关。
高血压患者总体膳食抗氧化剂摄入量较高与全因死亡率和CVD死亡率降低显著相关。需要进一步的随机对照试验来证实我们的发现。